| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58209a99602b20c360e8d2eb8b6bee97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate |
2004-09-20^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-04-09^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05a73f6fa8cd43e55c3edb897dbf810f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d0f3636b46213949ff809e11f7ffba |
| publicationDate |
2010-04-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2336215-T3 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITIONS OF MODAFINIL WITH MODIFIED RELEASE. |
| abstract |
A pharmaceutical composition in unit dose form, in which after administration to a patient, the composition releases two or more amounts of a modafinil compound, comprising a) a core particle comprising an effective amount of a modafinil compound ; b) a first membrane comprising an enteric polymer; c) a second membrane comprising a water insoluble polymer and an enteric polymer wherein the water insoluble polymer and the enteric polymer of the second membrane are present in the second membrane in a weight ratio of about 10: 1 to 1: one; wherein the core particle is coated with the first and second membranes, in any order, to form an active drug particle, and the total weight of the first and second membranes is approximately 15 to 80% by weight of the total weight of the active drug particle; and d) an immediate release formulation of a modafinil compound. |
| priorityDate |
2003-09-18^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |